New York Approves Medical Cannabis Trial Using THC Oral Solution for Sciatica Pain

The New York Cannabis Control Board has approved a groundbreaking clinical trial investigating VER-01, an oral THC solution, for treating chronic pain associated with lumbosacral radiculopathy (sciatica). This first-of-its-kind research represents a significant step in evaluating cannabis-derived therapeutics for neuropathic pain conditions. The study addresses a substantial patient population suffering from sciatica-related chronic pain who may benefit from alternative treatment options. This approval underscores growing regulatory recognition of cannabinoid-based medicines and their potential therapeutic applications in pain management.
Originally published on
Ganjapreneur
By TG Branfalt
Read full article(opens in new tab)Fetched: October 8, 2026 at 10:02 AM



